Showing 2211-2220 of 6036 results for "".
- Kubota Vision Announces Publication in Scientific Reports of Study Data for Wearable Myopia-Control Devicehttps://modernod.com/news/kubota-vision-announces-publication-in-scientific-reports-of-study-data-for-wearable-myopia-control-device/2480478/Kubota Vision announced the publication of a new paper in the journal Scientific Reports: Effect of short-term peripheral myopic defocus on ocular biometrics using Fresnel “press-on” lenses in humans. The paper
- CooperVision Launches Student Myopia Leadership Societyhttps://modernod.com/news/coopervision-launches-student-myopia-leadership-society/2480444/CooperVision has launched the CooperVision Student Myopia Leadership Society. Each of the 23 schools and colleges of optometry across the United States and Canada have designated a third-year student for participation, based on their interest in the disease, academic performance and other school-
- CooperVision Specialty EyeCare Launches Optimized Pupil Optics for Onefit MED and Onefit MED+ Scleral Lenseshttps://modernod.com/news/coopervision-specialty-eyecare-launches-optimized-pupil-optics-for-onefit-med-and-onefit-med-scleral-lenses/2480394/CooperVision Specialty EyeCare announced the launch of Optimized Pupil Optics (OPO) for its Onefit MED and Onefit MED+ scleral contact lenses to eye care providers (ECPs) in the United States and Canada. The new high precision design option—which is supported by an
- Eyenovia Announces Reclassification of MydCombi as Drug-Device Combination Product by FDAhttps://modernod.com/news/eyenovia-announces-reclassification-of-mydcombi-as-drug-device-combination-product-by-fda/2480375/In a Complete Response Letter (CRL) from the FDA, Eyenovia announced that MydCombi, the company’s proprietary, first-in-class combination microdose formulation of tropicamide and phenylephrine for in-office pupil dilation, has been reclassified as a drug-device com
- FDA Approves Genentech’s Port Delivery System, Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet AMDhttps://modernod.com/news/fda-approves-genentechs-port-delivery-system-susvimo-a-first-of-its-kind-therapeutic-approach-for-wet-amd/2480373/Genentech announced that the FDA has approved Susvimo (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant for the treatment of people with wet age-related macular degeneration (AMD) who have previously responded to at least two anti-vascular endothelial growth fact
- Orasis Pharmaceuticals Appoints Julie Speed as Senior Vice President, Head of Strategy and Marketing to Lead Commercial Growth Planhttps://modernod.com/news/orasis-pharmaceuticals-appoints-julie-speed-as-senior-vice-president-head-of-strategy-and-marketing-to-lead-commercial-growth-plan/2480321/Orasis Pharmaceuticals announced the appointment of Julie Speed as senior vice president (SVP), head of strategy and marketing. Ms. Speed brings over two decades of leadership in eye care and will be responsible for developing the brand strategy and building the marketin
- Zeiss Introduces New Devices and Software Applications as Part of Medical Ecosystemhttps://modernod.com/news/zeiss-introduces-a-series-of-innovations-and-software-applications-as-part-of-the-medical-ecosystem/2480290/As part of its innovation week, Zeiss introduced integrated solutions designed to bring value to the Zeiss Medical Ecosystem, connecting devices, data, and applications. Zeiss introduced a new integrated cataract workflow solution for lens replacement with the launch of t
- CNET: Mojo Vision Crams its Contact Lens with AR Display, Processor and Wireless Techhttps://modernod.com/news/cnet-mojo-vision-crams-its-contact-lens-with-ar-display-processor-and-wireless-tech/2479469/On Tuesday, startup Mojo Vision detailed its progress on a tiny AR display it embeds in contact lenses, providing a digital layer of information superimposed on what you see in the real world, according to a CNET
- Alcon to Launch TOTAL30 as the First Monthly Replacement, Water Gradient Contact Lenshttps://modernod.com/news/alcon-to-launch-total30-as-the-first-monthly-replacement-water-gradient-contact-lens/2479449/Alcon announced plans to launch TOTAL30, the first-and-only monthly replacement, water gradient lens. Using Alcon’s proprietary water gradient material first introduced with DAILIES TOTAL1 contact lenses, TOTAL30 delivers a premium wearing experience for reusable contact lens wearers, according t
- Visus Therapeutics Announces Executive Leadership Appointments in Operations, Research, Clinical Operations and Intellectual Propertyhttps://modernod.com/news/visus-therapeutics-announces-executive-leadership-appointments-in-operations-research-clinical-operations-and-intellectual-property/2479290/Visus Therapeutics announced the appointment of six new senior leaders, including Tim Grinstead as Chief Operating Officer; James Burke as Vice President of Research; Patrick Hughes, PhD, as Vice President of Pharmaceutical Development; Lisa Simpson as Vice President of Clinical Operations and Co